JP2018507204A5 - - Google Patents

Download PDF

Info

Publication number
JP2018507204A5
JP2018507204A5 JP2017543381A JP2017543381A JP2018507204A5 JP 2018507204 A5 JP2018507204 A5 JP 2018507204A5 JP 2017543381 A JP2017543381 A JP 2017543381A JP 2017543381 A JP2017543381 A JP 2017543381A JP 2018507204 A5 JP2018507204 A5 JP 2018507204A5
Authority
JP
Japan
Prior art keywords
antibiotic
decomposer
zinc
seq
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017543381A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018507204A (ja
JP6810697B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/019129 external-priority patent/WO2016137993A1/en
Publication of JP2018507204A publication Critical patent/JP2018507204A/ja
Publication of JP2018507204A5 publication Critical patent/JP2018507204A5/ja
Application granted granted Critical
Publication of JP6810697B2 publication Critical patent/JP6810697B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017543381A 2015-02-23 2016-02-23 腸内マイクロバイオームの保護のために抗生物質と共に使用するカルバペネマーゼ Active JP6810697B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201562119602P 2015-02-23 2015-02-23
US62/119,602 2015-02-23
US201562155621P 2015-05-01 2015-05-01
US62/155,621 2015-05-01
US201562190806P 2015-07-10 2015-07-10
US62/190,806 2015-07-10
PCT/US2016/019129 WO2016137993A1 (en) 2015-02-23 2016-02-23 Carbapenemases for use with antibiotics for the protection of the intestinal microbiome

Publications (3)

Publication Number Publication Date
JP2018507204A JP2018507204A (ja) 2018-03-15
JP2018507204A5 true JP2018507204A5 (https=) 2019-03-28
JP6810697B2 JP6810697B2 (ja) 2021-01-13

Family

ID=56789859

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017543381A Active JP6810697B2 (ja) 2015-02-23 2016-02-23 腸内マイクロバイオームの保護のために抗生物質と共に使用するカルバペネマーゼ

Country Status (7)

Country Link
US (4) US20160250304A1 (https=)
EP (1) EP3261662B1 (https=)
JP (1) JP6810697B2 (https=)
CN (1) CN107530406B (https=)
AU (1) AU2016222936B2 (https=)
CA (1) CA2977385C (https=)
WO (1) WO2016137993A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016222936B2 (en) * 2015-02-23 2022-01-06 Theriva Biologics, Inc. Carbapenemases for use with antibiotics for the protection of the intestinal microbiome
WO2018005606A1 (en) * 2016-06-28 2018-01-04 Synthetic Biologics, Inc. Microbiome protection from oral antibiotics
CN110269857A (zh) * 2018-03-14 2019-09-24 正大天晴药业集团股份有限公司 含阿维巴坦的抗菌组合物及其用途
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
CN109486802B (zh) * 2018-12-26 2020-08-04 广州白云山拜迪生物医药有限公司 一种酶活提高的青霉素酶突变体及其构建方法
CN112980803B (zh) * 2021-05-12 2021-07-30 天津一瑞生物科技股份有限公司 抗vim型碳青霉烯酶杂交瘤细胞株，单克隆抗体及应用
EP4148136A1 (en) * 2021-09-08 2023-03-15 Da Volterra An engineered yeast cell for the delivery of antibiotic-inactivating enzymes
CN114149988B (zh) * 2022-02-10 2022-05-06 丹娜(天津)生物科技股份有限公司 一种碳青霉烯酶保守抗原、抗体及其应用
WO2024012487A1 (en) * 2022-07-14 2024-01-18 The Hong Kong Polytechnic University Biosensor comprising a modified beta-lactamase and uses thereof
EP4553166A1 (en) * 2023-11-07 2025-05-14 MinervaX ApS Method for preparing a sample for analysis

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL89987C (https=) 1954-05-29
US2941995A (en) 1957-08-02 1960-06-21 Beecham Res Lab Recovery of solid 6-aminopenicillanic acid
US2982696A (en) 1959-05-01 1961-05-02 Schenley Ind Inc Ion-exchange procedures for the purification of penicillinase
US3070511A (en) 1960-02-10 1962-12-25 Lepetit Spa Process for preparing 6-aminopenicillanic acid
US3150059A (en) 1962-12-26 1964-09-22 Lilly Co Eli Penicillin deacylation via actinoplanaceae fermentation
US3239394A (en) 1964-06-15 1966-03-08 Merck & Co Inc Process for producing 7-amino-cephalosporanic acid
US3499909A (en) 1966-05-18 1970-03-10 Koninklijke Gist Spiritus Process for production of 6-aminopenicillanic acid
US3488729A (en) 1966-08-22 1970-01-06 Lilly Co Eli Cephalothin ester
GB1241844A (en) 1968-08-23 1971-08-04 Beecham Group Ltd Penicillins
FI59265C (fi) 1974-08-13 1981-07-10 Beecham Group Ltd Foerfarande foer framstaellning av 6-aminopenicillansyra
GB1463513A (en) 1974-08-13 1977-02-02 Beecham Group Ltd Enzymes
GB2199582A (en) 1987-01-07 1988-07-13 Bayer Ag Analogues of pancreatic secretory trypsin inhibitor
FR2613624B1 (fr) 1987-04-10 1990-11-23 Roussy Inst Gustave Composition pharmaceutique, administrable par voie orale, destinee a reduire les effets des b-lactamines
CA2007083A1 (en) 1989-01-09 1990-07-09 Nobuhiko Katunuma Pharmaceutical use of trypstatin
CS275231B2 (en) 1989-09-29 1992-02-19 Ustav Makormolekularni Chemie Medicine bottle
FI920206A0 (fi) 1992-01-17 1992-01-17 Pekka Untamo Heino Medicinsk anvaendning, medicinskt foerfarande och preparat.
WO1997003185A1 (en) 1995-07-07 1997-01-30 Novo Nordisk A/S Production of proteins using bacillus incapable of sporulation
US6630510B1 (en) * 1999-10-28 2003-10-07 Merck & Co., Inc. Substituted succinic acid metallo-β-lactamase inhibitors and their use in treating bacterial infections
US7585674B2 (en) 2001-05-29 2009-09-08 Kao Corporation Host microorganisms
FI112666B (fi) 2001-11-06 2003-12-31 Ipsat Therapies Oy Itiöimätön Bacillus subtilis, sen valmistus ja käyttö
FR2843302B1 (fr) 2002-08-09 2004-10-22 Centre Nat Rech Scient Forme galenique pour la delivrance colique de principes actifs
EP1564286A1 (en) 2004-02-11 2005-08-17 Université de Liège Hybrid proteins of beta-lactamase class A
AU2006249100B2 (en) 2005-05-18 2012-01-19 Assistance Publique - Hospitaux De Paris Colonic delivery of adsorbents
FI119190B (fi) 2006-06-21 2008-08-29 Ipsat Therapies Oy Modifioitu beta-laktamaasi ja menetelmä sen valmistamiseksi
FI119678B (fi) 2006-11-28 2009-02-13 Ipsat Therapies Oy Beta-laktamaasin käyttö
WO2011042454A1 (en) * 2009-10-06 2011-04-14 INSERM (Institut National de la Santé et de la Recherche Médicale) Carbapenemase and antibacterial treatment
FI20105572A0 (fi) * 2010-05-24 2010-05-24 Prevab R Lcc Muokattu beeta-laktamaasi ja siihen liittyvät menetelmät ja käytöt
CN102757950A (zh) * 2011-04-25 2012-10-31 天津市国际生物医药联合研究院 超级细菌新德里金属依赖型β-内酰胺酶NDM-1的表达纯化及β-内酰胺酶NDM-1的晶体结构
EP2729577B1 (en) * 2011-07-05 2016-06-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Selective culture medium and method for detecting carbapenem-resistant bacteria in a test sample
WO2013011072A1 (en) * 2011-07-20 2013-01-24 INSERM (Institut National de la Santé et de la Recherche Médicale) Carbapenemase and antibacterial treatment
US9129039B2 (en) * 2011-10-18 2015-09-08 Ut-Battelle, Llc Scenario driven data modelling: a method for integrating diverse sources of data and data streams
EP2814483A2 (en) * 2012-02-15 2014-12-24 Rempex Pharmaceuticals, Inc. Methods of treating bacterial infections
CN107148473B (zh) 2014-10-08 2021-08-06 合成生物制品有限公司 β-内酰胺酶制剂及其用途
AU2016222936B2 (en) * 2015-02-23 2022-01-06 Theriva Biologics, Inc. Carbapenemases for use with antibiotics for the protection of the intestinal microbiome

Similar Documents

Publication Publication Date Title
JP2018507204A5 (https=)
JP2018520654A5 (https=)
MX2018011384A (es) Arn de replicacion en trans.
MX375911B (es) Constructos de anticuerpo multiespecifico.
EA201692359A1 (ru) Композиция на основе нового штамма prrsv или его белков, продукт, их применение, вирус prrsv, выделенная нк и рекомбинантный вектор экспрессии для получения этого вируса
NZ609903A (en) Expression vector for high level expression of recombinant proteins
EA201300054A1 (ru) Полипептид, обладающий активностью бета-глюкозидазы, и его применение
EA201391394A1 (ru) Композиции и способы ингибирования экспрессии генов вируса гепатита в
MX2022003908A (es) Enzimas y aplicaciones de las mismas.
AR105822A1 (es) Análogos de insulina
JP2012095652A5 (https=)
ATE414144T1 (de) Kulturen von e1-immortalisierten zellen und verfahren zu deren kultivierung zur erhöhung der produktausbeuten davon
EA201201126A1 (ru) Полипептид, обладающий активностью целлобиогидролазы, и его применение
JP2011177189A5 (https=)
AR065075A1 (es) Vectores para la expresion multiple de genes
IN2015MN00436A (https=)
MX2019003360A (es) Vectores de expresion para una secrecion de proteina mejorada.
PH12015500771A1 (en) Novel fc gamma receptor iib variants
AR072832A1 (es) LINEAS DE CELULAS HOSPEDANTES DE PRODUCCION MEJORADA QUE CONTIENEN CONSTRUCCIONES DE VECTORES QUE COMPRENDEN UN CASETE DE EXPRESIoN DE DHFR (ENZIMA DIHIDROFOLATO REDUCTASA).
RU2017142878A (ru) Микроорганизм рода Escherichia, обладающий продуктивностью по L-триптофану, и способ получения L-триптофана с его использованием
JP2016515399A5 (https=)
RU2017141773A (ru) Микроорганизм рода Escherichia, продуцирующий L-триптофан, и способ получения L-триптофана с его использованием
JP2017524366A5 (https=)
RU2012141653A (ru) Способ получения растворимого рекомбинантного белка интерферона без денатурирования
RU2016152662A (ru) Микроорганизм рода Escherichia, продуцирующий L-триптофан, и способ продуцирования L-триптофана с использованием данного микроорганизма